Skip to content
Lower risk Drug recall · FDA · Published February 5, 2020

Pfizer Caduet Tablets Recall: Defective Packaging May Cause Moisture Issues

Pfizer recalls Caduet 10mg/20mg tablets due to potential defective packaging that may not seal properly, risking moisture exposure. Affected products were distributed with specific lot numbers and expiration dates.

🇺🇸 FDA recall #D-0841-2020DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Inc.235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer is recalling Caduet (amlodipine besylate/atorvastatin calcium) tablets that may have packaging with a notched rim causing inadequate moisture protection. This could lead to the medication degrading over time, but the recall does not indicate immediate harm to users. Read more at govinfonow.com/recall/37382-pfizer-caduet-tablets-recall-defective-packaging-may-cause-moisture-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/37382-pfizer-caduet-tablets-recall-defective-packaging-may-cause-moisture-issues · Updated October 5, 2026 · FDA enforcement record: FDA #D-0841-2020

Cite this page

“Pfizer Caduet Tablets Recall: Defective Packaging May Cause Moisture Issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37382-pfizer-caduet-tablets-recall-defective-packaging-may-cause-moisture-issues. Based on FDA recall #D-0841-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0841-2020%22&limit=1).

The FDA announced on Feb. 5, 2020, that Pfizer Inc. is recalling Caduet (amlodipine besylate/atorvastatin calcium) Tablets due to defective containers that may lack adequate moisture protection. The agency classified the Class II recall as voluntary and terminated.

How to tell if you have it

  • Brand: Pfizer
  • Product: Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle
  • NDC: 0069-2180-30
  • Lot #: CY0937
  • Expiration: 12/2021
  • Quantity: 141 bottles

The hazard

According to the FDA, products potentially were packaged in defective bottles with a notched rim. This defect could cause inadequate foil sealing, resulting in a lack of moisture protection for the tablets.

Context

GovInfoNow's records show Pfizer Inc. has had 71 other recalls on record since Nov. 26, 2012. Recent Pfizer recalls include a Sodium Bicarbonate Injection recall on Aug. 4, 2025, due to lack of sterility assurance, and a Bicillin L-A Injectable Suspension recall on July 10, 2025, involving particulate risk. Other recent recalls of similar products include Lupin Sertraline Tablets Recall (Nov. 5, 2025) and Harvard Drug Group Midodrine tablets recall (Feb. 17, 2026).

How to tell if you have this one

Check for Caduet tablets labeled 10 mg/20 mg, 30-count bottles, with lot number CY0937 and expiration date 12/2021. The product was distributed by Pfizer Labs in Germany.

  • Brand
    Pfizer
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA.
  • NDC
    0069-2150-30, 0069-2170-30, 0069-2190-30, 0069-2260-30, 0069-2160-30, 0069-2180-30, 0069-2250-30, 0069-2270-30, 0069-6180-30, 0069-6323-30, 0069-6565-30, 0069-6747-30, 0069-7810-30, 0069-7232-30, 0069-7654-30, 0069-7476-30
Recall numberProduct, codes & lotsQuantity
D-0841-2020Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2180-30.; Lot #: CY0937, Exp 12/2021141 bottles
D-0842-2020Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.; Lot #: CY0963, Exp 07/2022128 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Packaging

    Inspect the bottle for a notched rim that may cause inadequate sealing.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Feb 5, 202012. FDA classified it Class II: Feb 13, 202023. Published in FDA’s Enforcement Report: Feb 19, 202034. FDA terminated the recall: Mar 8, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0841-2020 (February 5, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0841-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA